Table of Contents

January 2013


In their January editorial, the PLOS Medicine Editors discuss a paper which shows discrepancies between internal company documents and published reports of industry-sponsored trials. However, a new initiative from the European Medicines Agency (EMA) which aims to ensure that clinical trial data are released once the marketing authorization process has ended may go some way to addressing concerns over transparency of clinical trial findings. With this initiative planned to start in January 2014, the editors argue that EMA will need to hold a firm course during 2013 while the details of the initiative are ironed out.

Image Credit: Mark Tighe at Flickr


Tackling Non-Communicable Diseases In Low- and Middle-Income Countries: Is the Evidence from High-Income Countries All We Need?

Shah Ebrahim, Neil Pearce, Liam Smeeth, Juan P. Casas, Shabbar Jaffar, Peter Piot


Translating Coverage Gains into Health Gains for All Women and Children: The Quality Care Opportunity

Wendy J. Graham, Affette McCaw-Binns, Stephen Munjanja

Health in Action

Research Articles

Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study

Norma C. Ware, Monique A. Wyatt, Elvin H. Geng, Sylvia F. Kaaya, Oche O. Agbaji, Winnie R. Muyindike, Guerino Chalamilla, Patricia A. Agaba

Related Articles

Erectile Dysfunction Severity as a Risk Marker for Cardiovascular Disease Hospitalisation and All-Cause Mortality: A Prospective Cohort Study

Emily Banks, Grace Joshy, Walter P. Abhayaratna, Leonard Kritharides, Peter S. Macdonald, Rosemary J. Korda, John P. Chalmers

Prioritizing Congenital Syphilis Control in South China: A Decision Analytic Model to Inform Policy Implementation

Nicholas X. Tan, Chara Rydzak, Li-Gang Yang, Peter Vickerman, Bin Yang, Rosanna W. Peeling, Sarah Hawkes, Xiang-Sheng Chen, Joseph D. Tucker